Abstract
Objective
Patients and Methods
Results
Conclusion
Abbreviations and Acronyms:
CDR (Clinical Dementia Rating), CI (confidence interval), MCI (mild cognitive impairment), OR (odds ratio)Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Mayo Clinic ProceedingsReferences
- Mild cognitive impairment: clinical characterization and outcome.Arch Neurol. 1999; 56: 303-308
- Mild cognitive impairment—beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment.J Intern Med. 2004; 256: 240-246
- Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review).Neurology. 2001; 56: 1133-1142
- Exercise level and cognitive decline: the MoVIES project.Alzheimer Dis Assoc Disord. 2004; 18: 57-64
- Changes in cognition and mortality in relation to exercise in late life: a population based study.PLoS One. 2008; 3: e3124
- Physical activity and risk of cognitive impairment and dementia in elderly persons.Arch Neurol. 2001; 58: 498-504
- A prospective study of physical activity and cognitive decline in elderly women: women who walk.Arch Intern Med. 2001; 161: 1703-1708
- Walking and dementia in physically capable elderly men.JAMA. 2004; 292: 1447-1453
- Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older.Ann Intern Med. 2006; 144: 73-81
- Leisure activities and the risk of dementia in the elderly.N Engl J Med. 2003; 348: 2508-2516
- Cognitive activity and incident AD in a population-based sample of older persons.Neurology. 2002; 59: 1910-1914
- Caloric intake and the risk of Alzheimer disease.Arch Neurol. 2002; 59: 1258-1263
- Leisure activities and the risk of amnestic mild cognitive impairment in the elderly.Neurology. 2006; 66: 821-827
- Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial.JAMA. 2008; 300: 1027-1037
- Physical exercise, aging, and mild cognitive impairment: a population-based study.Arch Neurol. 2010; 67: 80-86
- Engaging in cognitive activities, aging, and mild cognitive impairment: a population-based study.J Neuropsychiatry Clin Neurosci. 2011; 23: 149-154
- The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.Neuroepidemiology. 2008; 30: 58-69
- The Clinical Dementia Rating (CDR): current version and scoring rules.Neurology. 1993; 43: 2412-2414
- Mild cognitive impairment as a diagnostic entity.J Intern Med. 2004; 256: 183-194
- Leisure time physical activity and its relationship to coronary risk factors in a population-based sample; the Minnesota Heart Survey.Am J Epidemiol. 1985; 121: 570-579
- Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease.Arch Neurol. 1999; 56: 1274-1279
- Cognitive activity in older persons from a geographically defined population.J Gerontol B Psychol Sci Soc Sci. 1999; 54: P155-P160
- Patients with Alzheimer's disease have reduced activities in midlife compared with healthy control-group members.Proc Natl Acad Sci U S A. 2001; 98: 3440-3445
- Revision of dietary analysis software for the Health Habits and History Questionnaire.Am J Epidemiol. 1994; 139: 1190-1196
- Vegetables, unsaturated fats, moderate alcohol intake, and mild cognitive impairment.Dement Geriatr Cogn Disord. 2010; 29: 413-423
- A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis. 1987; 40: 373-383
- An inventory for measuring depression.Arch Gen Psychiatry. 1961; 4: 561-571
- Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients.J Pers Assess. 1996; 67: 588-597
- Physical exercise, cognitive activity, caloric intake, and mild cognitive impairment: The Mayo Clinic Study of Aging.Neurology. 2010; 74: A488
- Epidemiology: Beyond the Basics. Aspen Publishers, Inc, Gaithersburg, MD2000
- Physical activity, cognitive activity, and cognitive decline in a biracial community population.Arch Neurol. 2005; 62: 1750-1754
- Physical activity, diet, and risk of Alzheimer disease.JAMA. 2009; 302: 627-637
- Mediterranean diet and mild cognitive impairment.Arch Neurol. 2009; 66: 216-225
- Physical activity and health: a report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Atlanta, GA1996
- Exercise, experience and the aging brain.Neurobiol Aging. 2002; 23: 941-955
- Brain reserve hypothesis in dementia.J Alzheimers Dis. 2007; 12: 11-22
- An active and socially integrated lifestyle in late life might protect against dementia.Lancet Neurol. 2004; 3: 343-353
- Promising strategies for the prevention of dementia.Arch Neurol. 2009; 66: 1210-1215
Article info
Footnotes
Grant Support: This study was supported by grants from the National Institutes of Health (K01 MH068351, RR024150, U01 AG006786, K01 AG028573, P50 AG016574, R01 AR030582, and R01 NS033978), by the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program, by the RWJ Foundation (Harold Amos) Medical Faculty Development Program, and by the European Union Regional Development Fund (Project FNUSA-ICRC: CZ.1.05/1.1.00/02.0123).
Potential Competing Interests: Dr Knopman serves as deputy editor for Neurology, serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals, is an investigator in clinical trials sponsored by Baxter, Elan Pharmaceuticals, and Forest Pharmaceuticals, and receives research support from the National Institutes of Health. Dr Boeve receives publishing royalties for Behavioral Neurology of Dementia (Cambridge Medicine, 2009), and receives research support from Cephalon, Inc., and Allon Pharmaceuticals. Dr Petersen is the chair of the Data Monitoring Committee for Pfizer, Inc, and Janssen Alzheimer Immunotherapy, is a consultant for Elan Pharmaceuticals and GE Healthcare, and gave a Continuing Medical Education presentation for Novartis.